|
WO2020018785A1
|
|
Methods of treating angioedema
|
|
WO2019165252A1
|
|
Compositions comprising hepcidin and methods of use thereof
|
|
TW201927331A
|
|
Angiotensin compositions and methods related thereto
|
|
WO2018175633A1
|
|
Methods of inducing anti-malarial immune responses and compositions related thereto
|
|
BR112019014524A2
|
|
COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD
|
|
BR112019012257A2
|
|
Hepcidine administration methods
|
|
EP3509621A1
|
|
Methods of treating iron overload
|
|
WO2017184851A1
|
|
Compositions and methods for treating cancer
|
|
US2017218005A1
|
|
Compositions and methods related to gentamicin
|
|
WO2017120438A1
|
|
Methods for administering angiotensin ii
|
|
TW201740972A
|
|
Methods of administering HEPCIDIN
|
|
WO2017120440A1
|
|
Methods of administering vasopressors
|
|
MX2018008299A
|
|
Methods of administering hepcidin.
|
|
AU2015243990A1
|
|
Hepcidin mimetic peptides and uses thereof
|
|
CN106714812A
|
|
Compositions and methods for treating kidney disorders
|
|
CN105592855A
|
|
Compositions and methods for treating renal failure
|
|
AU2004201699A1
|
|
Therapeutic and diagnostic domain 1 Beta2GPI polypeptides and methods of using same
|
